Infusion Options recalls

Infusion Options has 76 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 21 Aug 2019. The most frequent reason is sterility.

Total recalls76since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 21 Aug 2019

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 76 100%Class III 0 0%

Why infusion options is recalled

By year

All infusion options recalls, newest first

76 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIPembrolizumab 200 MG / Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IICalcium Gluconate 1 Gm / Nacl 0.9% Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIOxaliplatin 145 MG / D5w Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IICetuximab 335 MG / Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIEribulin 1.12 MG / Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIDecitabine 40 MG / Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIFluorouracil 560 MG / IVP recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IICarboplatin 174 MG / Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIOxytocin Lactated Ringers Intravenous Solution recalledInfusion OptionsSterilityNY
DrugCLASS IIDarzalex 1008 MG / Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIPanitumumab 400 MG / Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIOrencia 750 mg QS 0.9% Nacl Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIRituximab 575 MG / 0.9% Nacl Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIAzacitidine 125 MG / Sub-q Syringe recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IINivolumab 480 MG / Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIRomiPLOStim 700 MCG/ SQ SYR recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIBleomycin Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIMitomycin 10 MG / Ivp Syringe recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIOndansetron 8 MG / Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIFosaprepitant 150 mg/ NS Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIPertuzumab 840 MG/250 ml0.9% Nacl Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIAlimta 785 mg QS 0.9% Nacl Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIDaratumumab 904 MG Qs Ns Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIVinblastine 10.9 MG / D5w Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIMethylprednisolone 10 MG / Ivp recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIErbitux 770 MG/ Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIDoxorubicin Liposomal 71 MG / D5W IVPB recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIRituxan 728 MG Qs 0.9% Nacl Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIBortezomib 2.5 mg / SQ Syringe recalled by Infusion OptionsInfusion OptionsSterilityNY
DrugCLASS IIIron Sucrose 200 mg / NS Ivpb recalled by Infusion OptionsInfusion OptionsSterilityNY

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.